Receive our newsletter – data, insights and analysis delivered to you
  1. News
October 27, 2021

USF Health researchers find D-dimer test also works for Covid-19 patients

Normally D-dimer levels are undetectable or detectable at very low levels, but they rise sharply when the body breaks down clots.

Researchers at the University of South Florida Health (USF Health) Morsani College of Medicine have found that the D-dimer test also works for Covid-19 patients.

The screening blood test, which was validated originally for seriously ill patients without Covid-19, is still useful to rule out pulmonary embolisms (PE) in hospitalised Covid-19 patients.

A single-centre diagnostic study was conducted to check the effectiveness of D-dimer testing at detecting PE in hospitalised patients.

The D-dimer test measures protein fragments of blood clots floating in the bloodstream.

If a blood clot formed in another part of the body moves to the blood vessels of the lung, it causes PE.

The clot can decrease blood flow and result in low oxygen levels.

Content from our partners
The added value of Qarad’s multilingual freephone service to their eIFU solution
Small and simple: how medical device manufacturers select materials
Precision wire: The future of bespoke medical treatment

Normally D-dimer levels are undetectable or detectable at very low levels, however, they increase sharply when the body breaks down clots.

USF Health internal medicine associate professor and vice-chair Dr Oxner said: “Our study found that clinicians can feel confident interpreting the D-dimer levels the same in Covid-19 patients as they do in every other patient; we don’t need a special (different) value for Covid-19 patients.

“So, in hospitalised Covid-19 patients, we can appropriately rule out a pulmonary embolism if D-dimer levels are low.”

According to research, people infected with Covid-19 have three to ten times more probability of developing PE compared to other hospitalised patients.

It is noted that a negative D-dimer test can help patients avoid invasive diagnostic tests, such as a computed tomography pulmonary angiogram.

Oxner further added: “The mechanisms of developing pulmonary embolisms may differ for Covid-19 patients, but the resulting physiology is the same for all patients. The little fragments of (undissolved) blood clots are still detectable with D-dimer.”

Related Companies

Topics in this article:
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy